|4Feb 13, 4:42 PM ET

T2 Biosystems, Inc. 4

4 · T2 Biosystems, Inc. · Filed Feb 13, 2017

Insider Transaction Report

Form 4
Period: 2017-02-09
Harding David
Chief Commercial Officer
Transactions
  • Award

    Restricted Stock Units

    2017-02-09+17,50017,500 total
    Common Stock (17,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-02-09+35,00035,000 total
    Exercise: $5.67Exp: 2027-02-08Common Stock (35,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments beginning on February 9, 2018.
  • [F3]The stock option vests in 48 monthly installments commencing February 9, 2017.

Documents

1 file
  • 4
    a4.xmlPrimary

    4